Myleran
Showing 76 - 95 of 95
Leukemia Trial (Busulfan (Zhejiang Otsuka Pharmaceutical Co. Ltd), Cytarabine(Actavis Italy S.p.A), Fludarabine (Bayer))
Unknown status
- Leukemia
- Busulfan (Zhejiang Otsuka Pharmaceutical Co. Ltd)
- +4 more
- (no location specified)
May 24, 2016
Hematologic Tumors, Anemia, Aplastic, Hemoglobinuria, Paroxysmal Trial in Tucson (haploidentical allogeneic PBSC transp)
Completed
- Hematologic Neoplasms
- +3 more
- haploidentical allogeneic PBSC transp
-
Tucson, ArizonaArizona Cancer Center/University Medical Center
Mar 1, 2016
Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in Detroit (drug, procedure, radiation)
No longer available
- Leukemia
- +5 more
- Busulfan
- +7 more
-
Detroit, MichiganBarbara Ann Karmanos Cancer Institute
Feb 26, 2016
Leukemia, Chronic Myelogenous Leukemia Trial in Houston (Fludarabine, Busulfan, NK cell infusion:)
Completed
- Leukemia
- Chronic Myelogenous Leukemia
- Fludarabine
- +8 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jan 4, 2016
Lymphoma Trial in Houston (Vorinostat, Gemcitabine, Busulfan)
Completed
- Lymphoma
- Vorinostat
- +8 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Nov 17, 2015
Leukemia Trial in Houston (Busulfan, Cyclophosphamide, G-CSF)
Withdrawn
- Leukemia
- Busulfan
- +3 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Aug 21, 2015
Hematological Disease Trial in Chicago (Melphalan, Fludarabine, Antithymocyte Globulin (ATG))
Terminated
- Hematological Disease
- Melphalan
- +4 more
-
Chicago, IllinoisUniversity of Chicago
Apr 10, 2015
Myelodysplastic Syndrome, Leukemia Trial in Houston (Thymoglobulin, Busulfan, Fludarabine)
Completed
- Myelodysplastic Syndrome
- Leukemia
- Thymoglobulin
- +7 more
-
Houston, TexasUT MD Anderson Cancer Center
May 6, 2015
MDS, Secondary Acute Myeloid Leukemia Trial in Worldwide (Reduced Intensity Conditioning, Myeloablative conditioning)
Terminated
- Myelodysplastic Syndromes
- Secondary Acute Myeloid Leukemia
- Reduced Intensity Conditioning
- Myeloablative conditioning
-
Düsseldorf, Germany
- +13 more
Apr 2, 2015
Acute Leukemia, Chronic Leukemia, Lymphoproliferative Disease Trial in Sao Paulo (Analyze the pharmacokinetics of busulfan for
Unknown status
- Acute Leukemia
- +4 more
- Analyze the pharmacokinetics of busulfan for transplantation
-
Sao Paulo, SP, BrazilHospital Israelita Albert Einstein
Dec 2, 2014
Leukemia, Lymphoma, MDS Trial in Cleveland (drug, radiation, procedure)
Completed
- Leukemia
- +3 more
- busulfan
- +5 more
-
Cleveland, OhioCase Medical Center, University Hospitals Seidman Cancer Center,
Jun 19, 2013
Leukemia, MDS Trial in Detroit (busulfan, cyclophosphamide, cyclosporine)
Completed
- Leukemia
- Myelodysplastic Syndromes
- busulfan
- +6 more
-
Detroit, MichiganBarbara Ann Karmanos Cancer Institute
Aug 6, 2012
Leukemia Trial in Houston (Busulfan, Fludarabine)
Completed
- Leukemia
-
Houston, TexasU.T.M.D. Anderson Cancer Center
May 23, 2012
Leukemia Trial in Houston (Imatinib Mesylate, Fludarabine (Fludara), Busulfan)
Terminated
- Leukemia
- Imatinib Mesylate
- +7 more
-
Houston, TexasUT MD Anderson Cancer Center
Apr 19, 2012
Hematologic Malignancies Trial in Houston (Busulfan, Fludarabine)
Completed
- Hematologic Malignancies
-
Houston, TexasUT MD Anderson Cancer Center
Jan 24, 2012
Chronic Myelogenous Leukemia Trial in Houston (Busulfan, Cyclophosphamide, Imatinib Mesylate)
Completed
- Chronic Myelogenous Leukemia
- Busulfan
- +3 more
-
Houston, TexasUT MD Anderson Cancer Center
Oct 31, 2011
Acute Myeloid Leukemia Trial in Memphis (Busulfan, Cyclophosphamide, Mesna)
Completed
- Acute Myeloid Leukemia
- Busulfan
- +2 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Apr 25, 2008